(NPR) U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests

U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests








Ellume Limited, an Australian company, manufactures a 15-minute at-home test for the coronavirus which causes COVID-19.



Ellume Limited


hide caption





toggle caption




Ellume Limited











U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests






The Food and Drug Administration gave emergency authorization to Ellume's rapid test in December, after it showed 96% accuracy in a U.S. clinical study.